Kadoma, Japan

Satoshi Yonishi

This inventor holds 6 USPTO granted patents. Top assignee: Fujisawa Pharmaceutical Company, Ltd.. Active years: 1984-1997.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Satoshi Yonishi. Retrieved from https://idiyas.com/inventor/satoshi-yonishi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.2

ph-index = 1

Forward Citations = 4(Granted Patents)


Location History:

  • Kadoma, JP (1984 - 1985)
  • Nishinomiya, JP (1996 - 1997)

Company Filing History:


Years Active: 1984-1997

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Satoshi Yonishi: Innovator in Pharmaceutical Chemistry

Introduction

Satoshi Yonishi is a prominent inventor based in Kadoma, Japan, known for his significant contributions to pharmaceutical chemistry. With a total of six patents to his name, Yonishi has made remarkable strides in the development of pyrrolidine derivatives, showcasing his expertise in this specialized field.

Latest Patents

One of Satoshi Yonishi's latest patents is focused on the "Process for producing pyrrolidine derivative and salt thereof." This innovative process involves the production of a compound defined by a general formula that incorporates heterocyclic lower alkyl groups and acyl components, highlighting Yonishi's advancement in synthetic methodologies.

Career Highlights

Currently working at Fujisawa Pharmaceutical Company, Ltd., Yonishi has been instrumental in driving forward the company's research initiatives. His work has significant implications for the pharmaceutical industry, contributing to the development of new medicinal compounds and therapeutic applications.

Collaborations

Throughout his career, Satoshi Yonishi has collaborated with esteemed colleagues including Yoshihiko Kitaura and Osamu Nakaguchi. These collaborations have enriched his research endeavors and played a vital role in furthering advancements in pharmaceutical sciences.

Conclusion

In summary, Satoshi Yonishi's innovative contributions, particularly in the realm of pyrrolidine derivatives, exemplify his status as a key inventor in pharmaceutical chemistry. His ongoing work at Fujisawa Pharmaceutical Company, Ltd., coupled with fruitful collaborations, ensures that Yonishi remains at the forefront of impactful research and development in the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…